These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20166965)

  • 41. 15 years of ATTEMPTS: a macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting.
    Ye J; Shin MC; Liang Q; He H; Yang VC
    J Control Release; 2015 May; 205():58-69. PubMed ID: 25483423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence.
    Giorello L; Clerico L; Pescarolo MP; Vikhanskaya F; Salmona M; Colella G; Bruno S; Mancuso T; Bagnasco L; Russo P; Parodi S
    Cancer Res; 1998 Aug; 58(16):3654-9. PubMed ID: 9721875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell penetrating peptides fail to induce an innate immune response in epithelial cells in vitro: implications for continued therapeutic use.
    Carter E; Lau CY; Tosh D; Ward SG; Mrsny RJ
    Eur J Pharm Biopharm; 2013 Sep; 85(1):12-9. PubMed ID: 23958314
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chaperone-rich cell lysate embedded with BCR-ABL peptide demonstrates enhanced anti-tumor activity against a murine BCR-ABL positive leukemia.
    Kislin KL; Marron MT; Li G; Graner MW; Katsanis E
    FASEB J; 2007 Jul; 21(9):2173-84. PubMed ID: 17327358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study.
    El-Andaloussi S; Järver P; Johansson HJ; Langel U
    Biochem J; 2007 Oct; 407(2):285-92. PubMed ID: 17627607
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biological effects of Tat cell-penetrating peptide: a multifunctional Trojan horse?
    Lee D; Pacheco S; Liu M
    Nanomedicine (Lond); 2014 Jan; 9(1):5-7. PubMed ID: 24354809
    [No Abstract]   [Full Text] [Related]  

  • 47. Heat shock protein-mediated cell penetration and cytosolic delivery of macromolecules by a telomerase-derived peptide vaccine.
    Lee SA; Kim BR; Kim BK; Kim DW; Shon WJ; Lee NR; Inn KS; Kim BJ
    Biomaterials; 2013 Oct; 34(30):7495-505. PubMed ID: 23827187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunodominant protein MIP_05962 from Mycobacterium indicus pranii displays chaperone activity.
    Sharma A; Equbal MJ; Pandey S; Sheikh JA; Ehtesham NZ; Hasnain SE; Chaudhuri TK
    FEBS J; 2017 May; 284(9):1338-1354. PubMed ID: 28296245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell-penetrating peptides: strategies for anticancer treatment.
    Raucher D; Ryu JS
    Trends Mol Med; 2015 Sep; 21(9):560-70. PubMed ID: 26186888
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent in vivo advances in cell-penetrating peptide-assisted drug delivery.
    Kurrikoff K; Gestin M; Langel Ü
    Expert Opin Drug Deliv; 2016; 13(3):373-87. PubMed ID: 26634750
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier.
    Young Kim H; Young Yum S; Jang G; Ahn DR
    Sci Rep; 2015 Jun; 5():11719. PubMed ID: 26114640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action.
    Freire JM; Veiga AS; Rego de Figueiredo I; de la Torre BG; Santos NC; Andreu D; Da Poian AT; Castanho MA
    FEBS J; 2014 Jan; 281(1):191-215. PubMed ID: 24286593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of regulated cell death by cell-penetrating peptides.
    Krautwald S; Dewitz C; Fändrich F; Kunzendorf U
    Cell Mol Life Sci; 2016 Jun; 73(11-12):2269-84. PubMed ID: 27048815
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell.
    Lönn P; Dowdy SF
    Expert Opin Drug Deliv; 2015; 12(10):1627-36. PubMed ID: 25994800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A membrane-permeable peptide containing the last 21 residues of the G alpha(s) carboxyl terminus inhibits G(s)-coupled receptor signaling in intact cells: correlations between peptide structure and biological activity.
    D'Ursi AM; Giusti L; Albrizio S; Porchia F; Esposito C; Caliendo G; Gargini C; Novellino E; Lucacchini A; Rovero P; Mazzoni MR
    Mol Pharmacol; 2006 Mar; 69(3):727-36. PubMed ID: 16332984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. On the biomedical promise of cell penetrating peptides: limits versus prospects.
    Foerg C; Merkle HP
    J Pharm Sci; 2008 Jan; 97(1):144-62. PubMed ID: 17763452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A peptide chaperone for transdermal drug delivery.
    Prausnitz MR
    Nat Biotechnol; 2006 Apr; 24(4):416-7. PubMed ID: 16601723
    [No Abstract]   [Full Text] [Related]  

  • 59. Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein.
    Kim M; Maeng J; Jung J; Kim HY; Kim HJ; Kwon Y; Lee K
    Eur J Pharm Sci; 2011 May; 43(1-2):25-31. PubMed ID: 21440624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Primary Mechanism of Cellular Internalization for a Short Cell- Penetrating Peptide as a Nano-Scale Delivery System.
    Liu BR; Huang YW; Korivi M; Lo S-Y; Aronstam RS; Lee H-J
    Curr Pharm Biotechnol; 2017; 18(7):569-584. PubMed ID: 28828981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.